Grant: Discovery Grants Program - Individual
McGill University
$26,000.00
Leptin as a modulator of glial activity in inflammation
EF 2014-15
Résumé
The adipocyte derived circulating hormone leptin, acts on hypothalamic neurons to regulate energy balance by suppressing appetite and increasing energy expenditure. Recent discoveries have demonstrated that leptin also affects other biological systems including immunity. Several studies have now demonstrated complex and direct interactions between leptin and immune mediators, most notably cytokines such as interleukin (IL)-1, both in the periphery and the brain. Previously we demonstrated a functional link between leptin and brain IL-1ß by showing, that the appetite suppressing effects of this hormone were mediated via the induction of this cytokine. In addition we reported that leptin could trigger other brain-orchestrated responses synonymous with the host?s response to exogenous pathogenic exposure including fever, an effect that is also IL-1ß dependent. This was the first evidence directly linking leptin with ?sickness? type behaviours, which led to our original hypothesis that it could act as a classical peripheral inflammatory signal to the brain. We subsequently confirmed this by neutralizing endogenous leptin, in animals treated with the bacterial lipopolysaccharide (LPS), a potent activator of pro-inflammatory cytokines in the periphery and the brain. This led to a suppression of the LPS induced sickness responses, which were accompanied with the attenuation of hypothalamic IL-1ß expression. In subsequent in vitro studies we identified the cellular targets of leptin in the brain for the induction of IL-1 to be microglia, which we have shown to express the functional leptin receptor. In addition to the direct induction of IL-1 we discovered that pre-incubation of primary microglial cells in culture over 24h rendered the cells more reactive to secondary inflammatory stimuli such as LPS, which resulted in a several-fold increase in IL-1ß output in the culture medium. This effect was not limited to IL-1ß but was also true for other cytokines and chemokines. The role of leptin in potentiating the microglial response to LPS appeared to be linked to morphological changes involving the cytoskeletal component actin. In addition, using a time lapse study to monitor these morphological changes over an extended period of time we showed that the effects of leptin were long lasting (up to 96 h) with the microglia remaining fully viable compared to the untreated and LPS treated cells which had undergone cell death 72 h into the study. Other than its direct effect on microglia our most recent discoveries have linked this hormone with the modulation of IL-1ß expressing neutrophil trafficking into the brain to propagate the inflammatory response, a process that we believe involves chemokine production by microglia. Cumulatively these preliminary observations led us to hypothesize that the role of leptin in immunity is that of a modulator of immune cell activity in the brain, which may include the orchestration of the inflammatory response via the promotion of cell to cell interactions. Because circulating leptin levels fluctuate across a multitude of conditions (e.g. obesity, anorexia) a role for this hormone in modulating immune cell function in the brain could have wide-ranging implications for neuro-inflammatory responses. Thus to address this hypothesis we will conduct both in vivo and in vitro approaches in mice to investigate: 1. how leptin modulates microglial viability and survival, 2. if preconditioning by high or low levels of the hormone (as found in obese or food restricted animals respectively) affect the microglial responses to immunogenic stimuli, 3. whether neutrophil borne IL-ß activates microglial cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2014-05553
Name nom
Luheshi, Giamal
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5107
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell secretion
Research subject fr
Sécrétions cellulaires
Partie
1
Nb partie
1
Application title
Leptin as a modulator of glial activity in inflammation
Keyword
NSERC
Application summary
The adipocyte derived circulating hormone leptin, acts on hypothalamic neurons to regulate energy balance by suppressing appetite and increasing energy expenditure. Recent discoveries have demonstrated that leptin also affects other biological systems including immunity. Several studies have now demonstrated complex and direct interactions between leptin and immune mediators, most notably cytokines such as interleukin (IL)-1, both in the periphery and the brain. Previously we demonstrated a functional link between leptin and brain IL-1ß by showing, that the appetite suppressing effects of this hormone were mediated via the induction of this cytokine. In addition we reported that leptin could trigger other brain-orchestrated responses synonymous with the host?s response to exogenous pathogenic exposure including fever, an effect that is also IL-1ß dependent. This was the first evidence directly linking leptin with ?sickness? type behaviours, which led to our original hypothesis that it could act as a classical peripheral inflammatory signal to the brain. We subsequently confirmed this by neutralizing endogenous leptin, in animals treated with the bacterial lipopolysaccharide (LPS), a potent activator of pro-inflammatory cytokines in the periphery and the brain. This led to a suppression of the LPS induced sickness responses, which were accompanied with the attenuation of hypothalamic IL-1ß expression. In subsequent in vitro studies we identified the cellular targets of leptin in the brain for the induction of IL-1 to be microglia, which we have shown to express the functional leptin receptor. In addition to the direct induction of IL-1 we discovered that pre-incubation of primary microglial cells in culture over 24h rendered the cells more reactive to secondary inflammatory stimuli such as LPS, which resulted in a several-fold increase in IL-1ß output in the culture medium. This effect was not limited to IL-1ß but was also true for other cytokines and chemokines. The role of leptin in potentiating the microglial response to LPS appeared to be linked to morphological changes involving the cytoskeletal component actin. In addition, using a time lapse study to monitor these morphological changes over an extended period of time we showed that the effects of leptin were long lasting (up to 96 h) with the microglia remaining fully viable compared to the untreated and LPS treated cells which had undergone cell death 72 h into the study. Other than its direct effect on microglia our most recent discoveries have linked this hormone with the modulation of IL-1ß expressing neutrophil trafficking into the brain to propagate the inflammatory response, a process that we believe involves chemokine production by microglia. Cumulatively these preliminary observations led us to hypothesize that the role of leptin in immunity is that of a modulator of immune cell activity in the brain, which may include the orchestration of the inflammatory response via the promotion of cell to cell interactions. Because circulating leptin levels fluctuate across a multitude of conditions (e.g. obesity, anorexia) a role for this hormone in modulating immune cell function in the brain could have wide-ranging implications for neuro-inflammatory responses. Thus to address this hypothesis we will conduct both in vivo and in vitro approaches in mice to investigate: 1. how leptin modulates microglial viability and survival, 2. if preconditioning by high or low levels of the hormone (as found in obese or food restricted animals respectively) affect the microglial responses to immunogenic stimuli, 3. whether neutrophil borne IL-ß activates microglial cells.